a Faculty of Biology, National Key Laboratory of Enzyme and Protein Technology , VNU University of Science , Hanoi , Vietnam.
b National Research Laboratory for Mitochondrial Signaling, Department of Physiology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease Center , College of Medicine, Inje University , Busan , Korea.
Free Radic Res. 2018 Dec;52(11-12):1210-1219. doi: 10.1080/10715762.2018.1516285. Epub 2018 Nov 23.
Decorin (DCN) is a proteoglycan constituent of the extracellular matrix (ECM) possessing powerful antifibrotic, anti-inflammation, antioxidant, and antiangiogenic properties. By attaching to receptors in the cell surface or to several ECM molecules, it regulates plenty of cellular functions, consequently influencing cell differentiation, proliferation, and apoptosis. These processes are dependent on cell types, biological contexts, and interfere with pathological processes such as cardiovascular diseases. In this review, we briefly discuss the potential of DCN targeting in addressing cardiovascular diseases (CVD). We dive into its interactome and discuss how its interaction with the proteins can affect disease progression, and how DCN can be a possible target for CVD therapeutics.
蛋白聚糖核心蛋白聚糖(DCN)是细胞外基质(ECM)的组成部分,具有强大的抗纤维化、抗炎、抗氧化和抗血管生成特性。它通过与细胞表面的受体或几种细胞外基质分子结合,调节多种细胞功能,从而影响细胞分化、增殖和凋亡。这些过程取决于细胞类型、生物背景,并干扰心血管疾病等病理过程。在这篇综述中,我们简要讨论了靶向 DCN 在治疗心血管疾病(CVD)中的潜力。我们深入探讨了其相互作用组,并讨论了其与蛋白质的相互作用如何影响疾病的进展,以及 DCN 如何成为 CVD 治疗的一个可能靶点。